203 related articles for article (PubMed ID: 35756487)
21. Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer.
Nie S; Ni N; Chen N; Gong M; Feng E; Liu J; Liu Q
J Ovarian Res; 2023 Apr; 16(1):82. PubMed ID: 37095524
[TBL] [Abstract][Full Text] [Related]
22. LncRNAs associated with vascular mimicry establish a novel molecular subtype and prognostic model for pancreatic cancer.
Li D; Zhang Q; Tang Y; Mao F; Zeng J; Ji A
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11571-11584. PubMed ID: 37400573
[TBL] [Abstract][Full Text] [Related]
23. Necroptosis-Related Prognostic Signature and Nomogram Model for Predicting the Overall Survival of Patients with Lung Cancer.
Xuan Y; Jin X; Wang M; Wang Z
Genet Res (Camb); 2022; 2022():4908608. PubMed ID: 36101745
[TBL] [Abstract][Full Text] [Related]
24. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
[TBL] [Abstract][Full Text] [Related]
25. A Four Autophagy-Related Gene-Based Prognostic Signature for Pancreatic Cancer.
Zhou Q; Chen X; Chen Q; Liu H; Hao L
Crit Rev Eukaryot Gene Expr; 2021; 31(4):89-100. PubMed ID: 34587439
[TBL] [Abstract][Full Text] [Related]
26. Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma.
Li C; Zou H; Xiong Z; Xiong Y; Miyagishima DF; Wanggou S; Li X
Front Genet; 2020; 11():429. PubMed ID: 32508873
[No Abstract] [Full Text] [Related]
27. Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma.
Zhang Q; Lv L; Ma P; Zhang Y; Deng J; Zhang Y
Front Immunol; 2021; 12():743938. PubMed ID: 34956177
[TBL] [Abstract][Full Text] [Related]
28. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
29. Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer.
Chen G; Liu Y; Su D; Qiu J; Long J; Zhao F; Tao J; Yang G; Huang H; Xiao J; Zhang T; Zhao Y
Cell Oncol (Dordr); 2023 Dec; 46(6):1691-1708. PubMed ID: 37434012
[TBL] [Abstract][Full Text] [Related]
30. Development of a novel necroptosis-associated miRNA risk signature to evaluate the prognosis of colon cancer patients.
Huang Y; Zou Y; Xiong Q; Zhang C; Sayagués JM; Shelat VG; Wang X
Ann Transl Med; 2021 Dec; 9(24):1800. PubMed ID: 35071494
[TBL] [Abstract][Full Text] [Related]
31. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes.
Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L
Front Genet; 2022; 13():919638. PubMed ID: 35783277
[No Abstract] [Full Text] [Related]
32. Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status.
Chen C; Wu Y; Chen K; Xia Z; Liu X; Zhang C; Zhao H; Shen A
Front Genet; 2022; 13():898507. PubMed ID: 35754846
[No Abstract] [Full Text] [Related]
33. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma.
Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J
Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472
[TBL] [Abstract][Full Text] [Related]
34. Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer.
Sun M; Ji X; Xie M; Chen X; Zhang B; Luo X; Feng Y; Liu D; Wang Y; Li Y; Liu B; Xia L; Huang W
Front Immunol; 2022; 13():999084. PubMed ID: 36544770
[TBL] [Abstract][Full Text] [Related]
35. A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer.
Zhang X; Zhang X; Li G; Hao Y; Liu L; Zhang L; Chen Y; Wu J; Wang X; Yang S; Xu S
J Immunol Res; 2022; 2022():3143511. PubMed ID: 35578667
[TBL] [Abstract][Full Text] [Related]
36. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
[TBL] [Abstract][Full Text] [Related]
37. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling.
Li N; Jia X; Wang Z; Wang K; Qu Z; Chi D; Sun Z; Jiang J; Cui Y; Wang C
Front Endocrinol (Lausanne); 2023; 14():1153909. PubMed ID: 37234801
[TBL] [Abstract][Full Text] [Related]
38. Identification of necroptosis-related signature and tumor microenvironment infiltration characteristics in lung adenocarcinoma.
Liu T; Guo L; Liu G; Dai Z; Wang L; Lin B; Hu X; Wang J; Zhang J
Lung Cancer; 2022 Oct; 172():75-85. PubMed ID: 36027854
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
Front Immunol; 2022; 13():977338. PubMed ID: 36159818
[TBL] [Abstract][Full Text] [Related]
40. Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer.
Wang H; Guo H; Sun J; Wang Y
Sci Rep; 2023 Aug; 13(1):13564. PubMed ID: 37604837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
